Salt Lake City-based Intermountain Healthcare and the Stanford Genome Technology Center, based in Palo Alto, Calif., have established a new collaborative research program that they say paves the way for scientific advances in precision health and medicine.
Here are six things to know about the research program.
1. The program includes a joint research team composed of members of SGTC, and Intermountain's Precision Genomics Core Laboratory, based in St. George, Utah.
2. This team of researchers, clinicians and other experts are trying to identify novel biomarkers using an advanced array of technologies developed at SGTC, both parties said. They said the focus of the joint research team will be on solving clinical issues for patients using technologies that enable delivery of precision health.
3. Additionally, the agreement between Intermountain and SGTC will provide scientific expertise and research support for Intermountain's Precision Genomics.
4. The collaboration between Intermountain and SGTC is part of a recently announced partnership between Intermountain and Stanford (Calif.) Medicine to support projects in research, patient care and medical education.
5. One of the primary objectives in the collaboration is to determine the clinical benefits associated with applying molecular analysis to patient care, both parties said.
6. In a prepared statement, Hanlee Ji, MD, senior associate director of SGTC and an associate professor at the Stanford School of Medicine in the division of oncology, said, "I'm honored to be part of this research program in which will we will address critical research questions in the development of precision health. Conducting our studies in collaboration with Intermountain Healthcare will enable our joint team to address more ambitious clinical research questions on a much broader scale."